X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (852) 852
Publication (78) 78
Newsletter (30) 30
Book Review (6) 6
Book Chapter (4) 4
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
phosphorylation (501) 501
casein kinase-2 (493) 493
biochemistry & molecular biology (431) 431
animals (359) 359
humans (356) 356
casein kinase ii (253) 253
index medicus (247) 247
cell biology (246) 246
amino acid sequence (203) 203
molecular sequence data (197) 197
casein kinase ii - metabolism (192) 192
protein-serine-threonine kinases - metabolism (173) 173
protein kinase ck2 (145) 145
ck2 (139) 139
beta-subunit (132) 132
proteins (132) 132
rats (132) 132
casein (131) 131
oncology (125) 125
kinases (120) 120
protein-kinase ck2 (119) 119
protein kinases (112) 112
protein kinases - metabolism (111) 111
casein kinases (108) 108
biophysics (104) 104
mice (101) 101
apoptosis (97) 97
expression (97) 97
signal transduction (95) 95
casein kinase ii - antagonists & inhibitors (94) 94
kinetics (87) 87
substrate specificity (83) 83
casein kinase 2 (80) 80
cellular-regulation (80) 80
life sciences (79) 79
male (79) 79
protein binding (79) 79
protein-serine-threonine kinases - chemistry (79) 79
casein kinase ii - genetics (77) 77
saccharomyces-cerevisiae (74) 74
cancer (71) 71
biochemistry, general (70) 70
cell line, tumor (70) 70
binding sites (68) 68
protein-serine-threonine kinases - genetics (67) 67
activation (65) 65
identification (64) 64
catalytic subunit (61) 61
protein kinase (61) 61
research (61) 61
recombinant proteins - metabolism (60) 60
proliferation (59) 59
alpha-subunit (58) 58
cardiology (58) 58
cells (58) 58
crystal-structure (58) 58
medical biochemistry (58) 58
cell line (57) 57
analysis (54) 54
protein kinase inhibitors - pharmacology (52) 52
protein phosphorylation (51) 51
inhibitors (50) 50
article (49) 49
casein kinase (49) 49
female (47) 47
ii-alpha (47) 47
mutation (46) 46
binding (45) 45
models, molecular (45) 45
casein kinase ii - chemistry (44) 44
inhibition (44) 44
cells, cultured (43) 43
animal structures (42) 42
enzyme inhibitors - pharmacology (42) 42
in-vitro (42) 42
site (42) 42
blotting, western (41) 41
catalytic domain (40) 40
gene expression (40) 40
protein structure, tertiary (40) 40
structure-activity relationship (39) 39
base sequence (38) 38
biochemistry (38) 38
fungi (38) 38
liver - enzymology (38) 38
embryonic structures (37) 37
enzyme activation (37) 37
tumors (37) 37
calmodulin (36) 36
gene (36) 36
neurosciences (36) 36
research article (36) 36
serine - metabolism (36) 36
cell cycle (35) 35
enzyme (35) 35
enzymes (35) 35
physiological aspects (35) 35
purification (35) 35
catalysis (34) 34
localization (34) 34
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell Death and Disease, ISSN 2041-4889, 02/2012, Volume 3, Issue 2, pp. e271 - e271
Glioblastoma multiforme (GBM) are resistant to TNF alpha-induced apoptosis and blockade of TNF alpha-induced NF-kappa B activation sensitizes glioma cells to... 
NF-κB | TNFα | Casein kinase-2 | Glioblastoma | p53 | GLIOMA-CELLS | CANCER-CELLS | CARCINOMA-CELLS | TNF alpha | PROTEIN-KINASE | DOWN-REGULATION | CK2 | CELL BIOLOGY | BREAST-CANCER | glioblastoma | NF-kappa B | GROWTH ARREST | NF-KAPPA-B | casein kinase-2 | RNA, Small Interfering - genetics | Protein Binding - genetics | Proto-Oncogene Proteins c-mdm2 - genetics | Apigenin - therapeutic use | Humans | Brain Neoplasms - pathology | Gene Expression Regulation, Neoplastic | NF-kappa B - metabolism | Casein Kinase II - genetics | Dichlororibofuranosylbenzimidazole - pharmacology | Sirtuin 1 - genetics | Brain Neoplasms - metabolism | Tumor Suppressor Protein p53 - genetics | Brain - metabolism | Telomerase - genetics | Transfection | Glioblastoma - genetics | Glioblastoma - metabolism | Telomerase - metabolism | Proto-Oncogene Proteins c-mdm2 - metabolism | Signal Transduction | Casein Kinase II - antagonists & inhibitors | Tumor Suppressor Protein p53 - metabolism | Brain Neoplasms - genetics | Sirtuin 1 - antagonists & inhibitors | Brain - drug effects | Tumor Necrosis Factor-alpha - pharmacology | NF-kappa B - genetics | Cell Cycle Checkpoints - drug effects | Dichlororibofuranosylbenzimidazole - therapeutic use | Glioblastoma - pathology | Brain - pathology | Cell Line, Tumor | Protein Kinase Inhibitors - pharmacology | Apigenin - pharmacology | Apoptosis | Original
Journal Article
Journal of Molecular Medicine, ISSN 0946-2716, 11/2017, Volume 95, Issue 11, pp. 1215 - 1226
Journal Article
Journal Article
FEBS Letters, ISSN 0014-5793, 2001, Volume 496, Issue 1, pp. 44 - 48
The specificity of 4,5,6,7‐tetrabromo‐2‐azabenzimidazole (TBB), an ATP/GTP competitive inhibitor of protein kinase casein kinase‐2 (CK2), has been examined... 
Casein kinase | Inhibitor | Casein kinase-2 | Protein phosphorylation | Protein kinase | nCK, native casein kinase | OA, okadaic acid | PRAK, p38-regulated/activated kinase | CSK, C-terminal Src kinase | AMPK, AMP-activated protein kinase | CHK, checkpoint kinase | JNK, c-Jun N-terminal kinase | MAPKAP, MAPK-activated protein kinase | p70S6K, p70 ribosomal protein S6 kinase | CK, casein kinase | SAPK, stress-activated protein kinase | PDK, 3-phosphoinositide-dependent kinase | ROCK, Rho-dependent protein kinase | CDK, cyclin-dependent kinase | G-CK, Golgi casein kinase | PKC, protein kinase C | MKK, MAPK kinase (also called MEK) | PKA, cAMP-dependent protein kinase | DRB, 1-(β-D-ribofuranosyl)-5,6-dichlorobenzimidazole | PHK, phosphorylase kinase | GSK3, glycogen synthase kinase 3 | PKB, protein kinase B (also called Akt) | rCK, recombinant casein kinase | ERK, extracellular signal-regulated kinase | HS1, hematopoietic lineage cell-specific protein 1 | MSK, mitogen- and stress-activated protein kinase | TBB, 4,5,6,7-tetrabromo-2-azabenzimidazole or 4,5,6,7-tetrabromobenzotriazole | MAPK, mitogen-activated protein kinase | SGK, serum- and glucocorticoid-induced kinase | CATALYTIC SUBUNIT | ZEA-MAYS | TYROSINE KINASE | CRYSTAL-STRUCTURE | COMPETITIVE INHIBITOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | protein phosphorylation | IMMUNOPHILIN FPR3 | SACCHAROMYCES-CEREVISIAE | protein kinase | CELL BIOLOGY | casein kinase | BIOPHYSICS | inhibitor | CELL-CYCLE | BETA-SUBUNIT | casein kinase-2 | MAMMARY-GLAND | Protein Kinases - metabolism | Jurkat Cells - cytology | Protein Kinases - drug effects | Casein Kinase II | Emodin - pharmacology | Jurkat Cells - metabolism | Humans | Enzyme Inhibitors - pharmacology | Protein-Serine-Threonine Kinases - genetics | Substrate Specificity | Adenosine Triphosphate | Binding Sites - genetics | Binding, Competitive - drug effects | Triazoles - pharmacology | Triazoles - metabolism | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Binding Sites - drug effects | Protein-Serine-Threonine Kinases - metabolism | Staurosporine - pharmacology | Amino Acid Substitution | Jurkat Cells - drug effects
Journal Article
by Eom, GH and Cho, YK and Ko, JH and Shin, S and Choe, N and Kim, Y and Joung, H and Kim, HS and Nam, KI and Kee, HJ and Kook, H
CIRCULATION, ISSN 0009-7322, 05/2011, Volume 123, Issue 21, pp. 2392 - U123
Background-Cardiac hypertrophy is characterized by transcriptional reprogramming of fetal gene expression, and histone deacetylases (HDACs) are tightly linked... 
HDAC2 | CARDIAC & CARDIOVASCULAR SYSTEMS | CHROMATIN | hypertrophy | ACETYLATION | PROTEIN-KINASE CK2 | histone deacetylase 2 S394 | casein kinase 2 | ANGIOTENSIN | INHIBITION | transgenic mice | GENE | CARDIAC-HYPERTROPHY | PERIPHERAL VASCULAR DISEASE | phosphorylation | EXPRESSION
Journal Article
Journal Article
Theoretical Chemistry Accounts: Theory, Computation, and Modeling (Theoretica Chimica Acta), ISSN 1432-881X, 03/2018, Volume 137, Issue 3, p. 1
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00214-018-2207-2 Halogen... 
Case studies | Casein | Hydrogen | Force and energy | Drug discovery
Journal Article
Scientific Reports, ISSN 2045-2322, 01/2017, Volume 7, Issue 1, p. 41295
The underlying mechanism of the reduced bone formation during the development of glucocorticoid-induced osteoporosis (GIO) remains unclear. Here, we found that... 
SYSTEM | ACTIVATION | MULTIDISCIPLINARY SCIENCES | MINERALIZATION | LIGASE SMURF1 | OSTEOSARCOMA | TERIPARATIDE | DIFFERENTIATION | MODULATION | MORPHOGENETIC PROTEIN-2 | SURFACES | Osteoporosis | Smad protein | Bone growth | Ubiquitination | Vitamin D | Casein | Glucocorticoids | Bone morphogenetic proteins | siRNA | Osteoblasts | Osteogenesis
Journal Article
Biochemical Journal, ISSN 0264-6021, 08/2009, Volume 421, Issue 3, pp. 387 - 395
Journal Article